Identifiability and estimation under the test-negative design with population controls with the goal of identifying risk and preventive factors for SARS-CoV-2 infection
Mireille E. Schnitzer, Daphna Harel, Vikki Ho, Anita Koushik and, Joanna Merckx

TL;DR
This paper explores the identifiability of risk factors for SARS-CoV-2 infection using an alternative study design that includes symptomatic, asymptomatic, and population controls, proposing a new estimator and comparing study designs.
Contribution
It introduces a novel study design and inverse probability weighting estimator for identifying risk factors, addressing limitations of the traditional test-negative design.
Findings
Identifiability conditions depend on data collection and study design.
The proposed estimator performs well in simulation studies.
Including asymptomatic individuals enhances risk factor identification.
Abstract
Due to the rapidly evolving COVID-19 pandemic caused by the SARS-CoV-2 virus, quick public health investigations of the relationships between behaviours and infection risk are essential. Recently the test-negative design was proposed to recruit and survey participants who are symptomatic and being tested for SARS-CoV-2 infection with the goal of evaluating associations between the survey responses (including behaviours and environment) and testing positive on the test. It was also proposed to recruit additional controls who are part of the general population as a baseline comparison group in order to evaluate risk factors specific to SARS-CoV-2 infection. In this study, we consider an alternative design where we recruit among all individuals, symptomatic and asymptomatic, being tested for the virus in addition to population controls. We define a regression parameter related to a…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
